Delivery Order SPE2DB22D9362-SPE2DB24FY25D

Award Date 8/28/24
Potential Completion Date 9/19/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 contract is for the delivery of Nexplanon 68 mg implants, a contraceptive product, to support the recurring medical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,867.25 contract is for the supply of Nexplanon 68 mg implants, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's broader $499,999,999 indefinite delivery contract (IDC)...
This is a contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,429.38 firm fixed-price delivery order is for 4,565,089,397 units of the Nexplanon 68 MG contraceptive implant, with a period of performance through July 24, 2024. This award is under a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 held by DMS Pharmaceutical Group with the DLA, which allows the agency to...
This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,145.90 firm fixed-price contract is for the supply of Nexplanon 68 mg implants, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows...
This is a $3,698.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,558,244,879 units of Nexplanon 68 mg implants, a contraceptive product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $3,573.45 contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,567,979,703 units of Nexplanon 68 mg implants, a contraceptive device, with a ceiling value of $33,326.88. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 68 mg Nexplanon contraceptive implants. The contract, valued at $2,734.96, is a task order under a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA worth up to $499,999,999. This IDC, under the Medical Supply Chain program, allows the DLA to place delivery orders for a broad range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,587.60 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a type of contraceptive implant, to support the medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
  • SPE2DB22D9362
    Indefinite Delivery Contract
  • SPE2DB22D9362-SPE2DB24FY25D
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $3,573.45 contract is for the supply of Nexplanon 68 mg implants, a contraceptive device, to support the recurring medical supply needs of military health facilities.

The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a comprehensive range of pharmaceutical products to fulfill the diverse medical requirements of Department of Defense (DoD) healthcare facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides both routine and critical medications, including branded, generic, and specialty drugs, to DoD and Department of Veterans Affairs (VA) medical centers through this and other prime vendor contracts.

Generated 11/27/24, 9:20 AM